These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4272823)

  • 1. The involvement of LD- and SD-region differences in MLC and CML: a three-cell experiment.
    Schendel DJ; Alter BJ; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1651-5. PubMed ID: 4272823
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic control of major complex histocompatibility antigens.
    Bcah FH
    Genetics; 1975 Jun; 79 Suppl():263-75. PubMed ID: 125215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SD vs. LD antigens as targets for lymphocyte-mediated cytotoxicity: study of a family presenting a recombination event within the MHR.
    Bonnard GD; Chappuis M; Glauser A; Mempel W; Baumann P; Grosse-Wilde H; Albert ED
    Transplant Proc; 1973 Dec; 5(4):1679-82. PubMed ID: 4130076
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies on the genetic basis for cell-mediated lympholysis in mice.
    Sorensen SF
    Transplant Proc; 1973 Dec; 5(4):1657-61. PubMed ID: 4130072
    [No Abstract]   [Full Text] [Related]  

  • 5. LD-SD interaction in vivo and the allograft reaction.
    van Rood JJ
    Transplant Proc; 1973 Dec; 5(4):1747-50. PubMed ID: 4272829
    [No Abstract]   [Full Text] [Related]  

  • 6. Proliferating helper-cell (PHC) test: a possible addition to the armamentarium for histocompatibility testing.
    Bach ML; Bach FH
    Transplant Proc; 1973 Dec; 5(4):1755-7. PubMed ID: 4272830
    [No Abstract]   [Full Text] [Related]  

  • 7. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Sep; 5(3):1301-7. PubMed ID: 4125685
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; Du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Mar; 5(1):415-20. PubMed ID: 4121172
    [No Abstract]   [Full Text] [Related]  

  • 9. The specificty and the activation mechanism of cell-mediated lympholysis (CML) in man.
    Eijsvoogel VP; du Bois MJ; Meinesz A; Bierhorst-Eijlander A; Zeylemaker WP; Schellekens PT
    Transplant Proc; 1973 Dec; 5(4):1675-8. PubMed ID: 4130075
    [No Abstract]   [Full Text] [Related]  

  • 10. T cells in mixed-lymphocyte-culture-induced cytolysis (MLC-CML).
    Häyry P; Andersson LC
    Transplant Proc; 1973 Dec; 5(4):1697-703. PubMed ID: 4272824
    [No Abstract]   [Full Text] [Related]  

  • 11. MLC and CMC reactivity and specificity of idiotype-specific lymphoid cells enriched for histocompatibility (H-2) antigens.
    Folks TM; Ahmed A; Ryan JJ; Feldmann M; Woody J; Sell KW
    Transplant Proc; 1979 Mar; 11(1):683-9. PubMed ID: 88095
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped families.
    Mawas C; Sasportes M; Christen Y; Bernard A; Dausset J; Alter BJ; Bach ML
    Transplant Proc; 1973 Dec; 5(4):1683-9. PubMed ID: 4130077
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancing antibody: in vitro studies on mechanism of action upon the sensitization and effector arc.
    Phillips SM; Strom TB; Corson JM; Carpenter CB; Merrill JP
    Transplant Proc; 1973 Mar; 5(1):577-80. PubMed ID: 4266670
    [No Abstract]   [Full Text] [Related]  

  • 14. The genetic basis for cell-mediated lympholysis in mice.
    Sorensen SF; Hawkes SP
    Transplant Proc; 1973 Dec; 5(4):1361-6. PubMed ID: 4272808
    [No Abstract]   [Full Text] [Related]  

  • 15. The response of alloimmune human lymphocytes in mixed lymphocyte culture tests.
    Bondevik H; Thorsby E
    Transplant Proc; 1973 Dec; 5(4):1477-80. PubMed ID: 4272813
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of H-2 LD and CD antigens in induction of in vitro unresponsiveness.
    Kuperman OJ; Sollinger HW; Bach FH
    Transplant Proc; 1977 Mar; 9(1):915-7. PubMed ID: 141141
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing immunological responses to experimental allografts.
    Hamburger J; Debray-Sachs M; Dimitriu A; Dy M; Caraux J
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):85-91. PubMed ID: 4280168
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region.
    Mayr WR; Bernoco D; De Marchi M; Ceppellini R
    Transplant Proc; 1973 Dec; 5(4):1581-93. PubMed ID: 4130068
    [No Abstract]   [Full Text] [Related]  

  • 20. Serologic detection of antigens controlled by the Ir region of the H-2 complex in the mouse.
    Hauptfeld V; Klein D; Klein J
    Transplant Proc; 1973 Dec; 5(4):1811-3. PubMed ID: 4149550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.